U.S. Prosthetic Heart Valve Market: Opportunity Analysis and Industry Forecast, 2024-2033

The U.S. prosthetic heart valve market was valued at $3.2 billion in 2023, and is projected to reach $8.9 billion by 2033, growing at a CAGR of 10.7% from 2024 to 2033.

Prosthetic heart valve is a medical device implanted in the heart to replace a diseased or damaged valve that cannot regulate blood flow effectively. These artificial valves are designed to mimic the function of natural heart valves, ensuring proper one-way blood flow through the heart and preventing leakage. Prosthetic heart valves are primarily used to treat conditions such as valve stenosis (narrowing) or valve regurgitation (leakage), which can compromise heart function and overall health.

The growth of the U.S. prosthetic heart valve market is driven by alarming rise in the prevalence of cardiovascular conditions such as aortic stenosis and mitral regurgitation. According to a study published by the Centers for Disease Control and Prevention in 2024, heart disease is the leading cause of death in the U.S., resulting in 702,880 deaths in 2022. The study further highlighted that one individual dies every 33 seconds due to cardiovascular disease. This highlights the urgent need for prosthetic heart valves, thus augmenting the market growth. In addition, surge in geriatric population significantly contributes toward the market growth.

This is attributed to the fact that this demographic has a higher susceptibility to heart valve degeneration. As per the 2024 data recorded by the Population Reference Bureau, the number of Americans aging 65 years and older was 58 million in 2022, and is estimated to reach 82 million by 2050. Furthermore, increase in awareness of screening programs acts as the key driving force of the market. For instance, the Million Hearts® is a national initiative co-led by the Centers for Disease Control and Prevention, which focuses on preventing 1 million heart attacks and strokes within 5 years. Moreover, rise in adoption of minimally invasive procedures and supportive reimbursement policies strengthen the market growth.

However, high costs of prosthetic valves and procedures acts as the key deterrent factor of the market. In addition, risk of post-surgical complications such as thrombosis, structural valve degeneration, and endocarditis restrains the market growth. On the contrary, innovations such as transcatheter aortic valve replacement have revolutionized treatment, offering minimally invasive options for patients who are high-risk for open-heart surgery. Such developments are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The U.S. prosthetic heart valve market is segmented on the basis of product. By product, the market is categorized into mechanical heart valve, tissue heart valve, and transcatheter heart valve. The tissue heart valve segment is further classified into stented tissue heart valve and stent less tissue heart valve.

Key Findings

The transcatheter heart valve segment generated the largest revenue in U.S. prosthetic heart valve market share in 2023, and is expected to continue the same trend from 2024 to 2033.

Competition Analysis

Competitive analysis and profiles of the major players in the global U.S. prosthetic heart valve market include Abbott Laboratories, Artivion, Inc, Anteris Technologies Ltd, Boston Scientific Corporation, Edward Lifesciences Corporation, JenaValve Technology, Inc., Colibri Heart Valve, Medtronic plc, Meril Life Sciences Pvt. Ltd., and ShockWave Medical, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update* (with the purchase of an enterprise license)
5 additional Company Profiles, pre- or post-purchase, as a free update.
Free Updated Version (once released) with the purchase of an enterprise user license.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

Tissue Heart Valve
Stented Tissue Heart Valve
Stentless Tissue Heart Valve
Mechanical Heart Valve
Transcatheter Heart Valve

Key Market Players

Abbott Laboratories
Artivion, Inc
Anteris Technologies Ltd
Boston Scientific Corporation
Edward Lifesciences Corporation
JenaValve Technology, Inc.
Colibri Heart Valve
Medtronic plc
Meril Life Sciences Pvt. Ltd.
ShockWave Medical, Inc.

Please note:

Online Access price format is valid for 60 days access. Printing is not enabled.
PDF Single and Enterprise price formats enable printing.

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

CHAPTER 4: U.S. PROSTHETIC HEART VALVE MARKET, BY PRODUCT

4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Tissue Heart Valve
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Stented Tissue Heart Valve
4.2.3. Stentless Tissue Heart Valve
4.3. Mechanical Heart Valve
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.4. Transcatheter Heart Valve
4.4.1. Key Market Trends, Growth Factors and Opportunities

CHAPTER 5: COMPETITIVE LANDSCAPE

5.1. Introduction
5.2. Top Winning Strategies
5.3. Product Mapping Of Top 10 Player
5.4. Competitive Dashboard
5.5. Competitive Heatmap
5.6. Top Player Positioning,2023

CHAPTER 6: COMPANY PROFILES

6.1. Abbott Laboratories
6.1.1. Company Overview
6.1.2. Key Executives
6.1.3. Company Snapshot
6.1.4. Operating Business Segments
6.1.5. Product Portfolio
6.1.6. Business Performance
6.1.7. Key Strategic Moves and Developments
6.2. Artivion, Inc
6.2.1. Company Overview
6.2.2. Key Executives
6.2.3. Company Snapshot
6.2.4. Operating Business Segments
6.2.5. Product Portfolio
6.2.6. Business Performance
6.2.7. Key Strategic Moves and Developments
6.3. Anteris Technologies Ltd
6.3.1. Company Overview
6.3.2. Key Executives
6.3.3. Company Snapshot
6.3.4. Operating Business Segments
6.3.5. Product Portfolio
6.3.6. Business Performance
6.3.7. Key Strategic Moves and Developments
6.4. Boston Scientific Corporation
6.4.1. Company Overview
6.4.2. Key Executives
6.4.3. Company Snapshot
6.4.4. Operating Business Segments
6.4.5. Product Portfolio
6.4.6. Business Performance
6.4.7. Key Strategic Moves and Developments
6.5. Edward Lifesciences Corporation
6.5.1. Company Overview
6.5.2. Key Executives
6.5.3. Company Snapshot
6.5.4. Operating Business Segments
6.5.5. Product Portfolio
6.5.6. Business Performance
6.5.7. Key Strategic Moves and Developments
6.6. JenaValve Technology, Inc.
6.6.1. Company Overview
6.6.2. Key Executives
6.6.3. Company Snapshot
6.6.4. Operating Business Segments
6.6.5. Product Portfolio
6.6.6. Business Performance
6.6.7. Key Strategic Moves and Developments
6.7. Colibri Heart Valve
6.7.1. Company Overview
6.7.2. Key Executives
6.7.3. Company Snapshot
6.7.4. Operating Business Segments
6.7.5. Product Portfolio
6.7.6. Business Performance
6.7.7. Key Strategic Moves and Developments
6.8. Medtronic Plc
6.8.1. Company Overview
6.8.2. Key Executives
6.8.3. Company Snapshot
6.8.4. Operating Business Segments
6.8.5. Product Portfolio
6.8.6. Business Performance
6.8.7. Key Strategic Moves and Developments
6.9. Meril Life Sciences Pvt. Ltd.
6.9.1. Company Overview
6.9.2. Key Executives
6.9.3. Company Snapshot
6.9.4. Operating Business Segments
6.9.5. Product Portfolio
6.9.6. Business Performance
6.9.7. Key Strategic Moves and Developments
6.10. ShockWave Medical, Inc.
6.10.1. Company Overview
6.10.2. Key Executives
6.10.3. Company Snapshot
6.10.4. Operating Business Segments
6.10.5. Product Portfolio
6.10.6. Business Performance
6.10.7. Key Strategic Moves and Developments

LIST OF TABLES

TABLE 1. U.S. PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 3. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 4. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 5. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 6. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 7. ARTIVION, INC: KEY EXECUTIVES
TABLE 8. ARTIVION, INC: COMPANY SNAPSHOT
TABLE 9. ARTIVION, INC: OPERATING SEGMENTS
TABLE 10. ARTIVION, INC: PRODUCT PORTFOLIO
TABLE 11. ARTIVION, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 12. ANTERIS TECHNOLOGIES LTD: KEY EXECUTIVES
TABLE 13. ANTERIS TECHNOLOGIES LTD: COMPANY SNAPSHOT
TABLE 14. ANTERIS TECHNOLOGIES LTD: OPERATING SEGMENTS
TABLE 15. ANTERIS TECHNOLOGIES LTD: PRODUCT PORTFOLIO
TABLE 16. ANTERIS TECHNOLOGIES LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 17. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 18. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 19. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 20. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 21. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 22. EDWARD LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 23. EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 24. EDWARD LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 25. EDWARD LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 26. EDWARD LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 27. JENAVALVE TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 28. JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 29. JENAVALVE TECHNOLOGY, INC.: OPERATING SEGMENTS
TABLE 30. JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 31. JENAVALVE TECHNOLOGY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 32. COLIBRI HEART VALVE: KEY EXECUTIVES
TABLE 33. COLIBRI HEART VALVE: COMPANY SNAPSHOT
TABLE 34. COLIBRI HEART VALVE: OPERATING SEGMENTS
TABLE 35. COLIBRI HEART VALVE: PRODUCT PORTFOLIO
TABLE 36. COLIBRI HEART VALVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 37. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 38. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 39. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 40. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 41. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 42. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 43. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 44. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 45. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 46. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 47. SHOCKWAVE MEDICAL, INC.: KEY EXECUTIVES
TABLE 48. SHOCKWAVE MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 49. SHOCKWAVE MEDICAL, INC.: OPERATING SEGMENTS
TABLE 50. SHOCKWAVE MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 51. SHOCKWAVE MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 1. U.S. PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF U.S. PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN U.S. PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: U.S. PROSTHETIC HEART VALVE MARKET
FIGURE 10. U.S. PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($BILLION)
FIGURE 11. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 12. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 13. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 14. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 15. COMPETITIVE DASHBOARD
FIGURE 16. COMPETITIVE HEATMAP: U.S. PROSTHETIC HEART VALVE MARKET
FIGURE 17. TOP PLAYER POSITIONING,2023
FIGURE 18. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 19. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 20. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 21. ARTIVION, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 22. ARTIVION, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. ARTIVION, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. ANTERIS TECHNOLOGIES LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. ANTERIS TECHNOLOGIES LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. ANTERIS TECHNOLOGIES LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. EDWARD LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. EDWARD LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. EDWARD LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. JENAVALVE TECHNOLOGY, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. COLIBRI HEART VALVE: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. COLIBRI HEART VALVE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. COLIBRI HEART VALVE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MEDTRONIC PLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. SHOCKWAVE MEDICAL, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)

LIST OF TABLES

Table 1. U.S. Prosthetic Heart Valve Market, by Product, 2024 - 2033 ($Billion)
Table 2. Abbott Laboratories: Key Executives
Table 3. Abbott Laboratories: Company Snapshot
Table 4. Abbott Laboratories: Operating Segments
Table 5. Abbott Laboratories: Product Portfolio
Table 6. Abbott Laboratories: Key Strategic Moves and Developments
Table 7. Artivion, Inc.: Key Executives
Table 8. Artivion, Inc.: Company Snapshot
Table 9. Artivion, Inc.: Operating Segments
Table 10. Artivion, Inc.: Product Portfolio
Table 11. Artivion, Inc.: Key Strategic Moves and Developments
Table 12. Anteris Technologies Ltd.: Key Executives
Table 13. Anteris Technologies Ltd.: Company Snapshot
Table 14. Anteris Technologies Ltd.: Operating Segments
Table 15. Anteris Technologies Ltd.: Product Portfolio
Table 16. Anteris Technologies Ltd.: Key Strategic Moves and Developments
Table 17. Boston Scientific Corporation: Key Executives
Table 18. Boston Scientific Corporation: Company Snapshot
Table 19. Boston Scientific Corporation: Operating Segments
Table 20. Boston Scientific Corporation: Product Portfolio
Table 21. Boston Scientific Corporation: Key Strategic Moves and Developments
Table 22. Edward Lifesciences Corporation: Key Executives
Table 23. Edward Lifesciences Corporation: Company Snapshot
Table 24. Edward Lifesciences Corporation: Operating Segments
Table 25. Edward Lifesciences Corporation: Product Portfolio
Table 26. Edward Lifesciences Corporation: Key Strategic Moves and Developments
Table 27. Jenavalve Technology, Inc.: Key Executives
Table 28. Jenavalve Technology, Inc.: Company Snapshot
Table 29. Jenavalve Technology, Inc.: Operating Segments
Table 30. Jenavalve Technology, Inc.: Product Portfolio
Table 31. Jenavalve Technology, Inc.: Key Strategic Moves and Developments
Table 32. Colibri Heart Valve: Key Executives
Table 33. Colibri Heart Valve: Company Snapshot
Table 34. Colibri Heart Valve: Operating Segments
Table 35. Colibri Heart Valve: Product Portfolio
Table 36. Colibri Heart Valve: Key Strategic Moves and Developments
Table 37. Medtronic PLC: Key Executives
Table 38. Medtronic PLC: Company Snapshot
Table 39. Medtronic PLC: Operating Segments
Table 40. Medtronic PLC: Product Portfolio
Table 41. Medtronic PLC: Key Strategic Moves and Developments
Table 42. Meril Life Sciences Pvt. Ltd.: Key Executives
Table 43. Meril Life Sciences Pvt. Ltd.: Company Snapshot
Table 44. Meril Life Sciences Pvt. Ltd.: Operating Segments
Table 45. Meril Life Sciences Pvt. Ltd.: Product Portfolio
Table 46. Meril Life Sciences Pvt. Ltd.: Key Strategic Moves and Developments
Table 47. Shockwave Medical, Inc.: Key Executives
Table 48. Shockwave Medical, Inc.: Company Snapshot
Table 49. Shockwave Medical, Inc.: Operating Segments
Table 50. Shockwave Medical, Inc.: Product Portfolio
Table 51. Shockwave Medical, Inc.: Key Strategic Moves and Developments

LIST OF FIGURES

Figure 1. U.S. Prosthetic Heart Valve Market,2024 - 2033
Figure 2. Segmentation of U.S. Prosthetic Heart Valve Market,2024 - 2033
Figure 3. Top Investment Pocket in U.S. Prosthetic Heart Valve Market,2024 - 2033
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: U.S. Prosthetic Heart Valve Market
Figure 10. U.S. Prosthetic Heart Valve Market , by Product,2024 - 2033 ($Billion)
Figure 11. Top Winning Strategies, by Year, 2021-2023*
Figure 12. Top Winning Strategies, by Development, 2021-2023*
Figure 13. Top Winning Strategies, by Company, 2021-2023*
Figure 14. Product Mapping of Top 10 Players
Figure 15. Competitive Dashboard
Figure 16. Competitive Heatmap: U.S. Prosthetic Heart Valve Market
Figure 17. Top Player Positioning,2023
Figure 18. Abbott Laboratories: Net Sales, 2021-2023 ($Billion)
Figure 19. Abbott Laboratories: Revenue Share, by Segment, 2023 (%)
Figure 20. Abbott Laboratories: Revenue Share, by Region, 2023 (%)
Figure 21. Artivion, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 22. Artivion, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 23. Artivion, Inc.: Revenue Share, by Region, 2023 (%)
Figure 24. Anteris Technologies Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 25. Anteris Technologies Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 26. Anteris Technologies Ltd.: Revenue Share, by Region, 2023 (%)
Figure 27. Boston Scientific Corporation: Net Sales, 2021-2023 ($Billion)
Figure 28. Boston Scientific Corporation: Revenue Share, by Segment, 2023 (%)
Figure 29. Boston Scientific Corporation: Revenue Share, by Region, 2023 (%)
Figure 30. Edward Lifesciences Corporation: Net Sales, 2021-2023 ($Billion)
Figure 31. Edward Lifesciences Corporation: Revenue Share, by Segment, 2023 (%)
Figure 32. Edward Lifesciences Corporation: Revenue Share, by Region, 2023 (%)
Figure 33. Jenavalve Technology, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 34. Jenavalve Technology, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 35. Jenavalve Technology, Inc.: Revenue Share, by Region, 2023 (%)
Figure 36. Colibri Heart Valve: Net Sales, 2021-2023 ($Billion)
Figure 37. Colibri Heart Valve: Revenue Share, by Segment, 2023 (%)
Figure 38. Colibri Heart Valve: Revenue Share, by Region, 2023 (%)
Figure 39. Medtronic PLC: Net Sales, 2021-2023 ($Billion)
Figure 40. Medtronic PLC: Revenue Share, by Segment, 2023 (%)
Figure 41. Medtronic PLC: Revenue Share, by Region, 2023 (%)
Figure 42. Meril Life Sciences Pvt. Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 43. Meril Life Sciences Pvt. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 44. Meril Life Sciences Pvt. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 45. Shockwave Medical, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 46. Shockwave Medical, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 47. Shockwave Medical, Inc.: Revenue Share, by Region, 2023 (%)

Companies Mentioned

Abbott Laboratories
Artivion, Inc
Anteris Technologies Ltd
Boston Scientific Corporation
Edward Lifesciences Corporation
JenaValve Technology, Inc.
Colibri Heart Valve
Medtronic plc
Meril Life Sciences Pvt. Ltd.
ShockWave Medical, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic news articles and other related releases for market evaluation
Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

LOADING...

Table Information

Report Attribute	Details
No. of Pages	90
Published	October 2024
Forecast Period	2023 - 2033
Estimated Market Value ( USD ) in 2023	$ 3.2 billion
Forecasted Market Value ( USD ) by 2033	$ 8.9 billion
Compound Annual Growth Rate	10.7%
Regions Covered	United States
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE Online Access		This is a single user license, allowing one user access to the product.	€2151EUR$2,177USD£1,776GBP
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3586EUR$3,629USD£2,961GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€6006EUR$6,078USD£4,959GBP

Key Findings

Competition Analysis

Additional benefits you will get with this purchase are:

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Key Market Segments

By Product

Key Market Players

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Prosthetic Heart Valves Market 2024-2028

Prosthetic Heart Valve Market By Product: Global Opportunity Analysis and Industry Forecast, 2024-2035

Transcatheter Aortic Valve Replacement Market 2024-2028

Prosthetic Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Transcatheter Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update